Lv5
819 积分 2024-11-15 加入
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
6天前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
6天前
已完结
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression
9天前
已完结
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
14天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
23天前
已完结
Diagnosis and Management of Paroxysmal Supraventricular Tachycardia
24天前
已完结
室上性心动过速诊断及治疗中国专家共识(2021)
24天前
已完结
Nefecon in IgA nephropathy: real-world renal efficacy, safety profile, and treatment response from a 9-month retrospective cohort analysis
24天前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
24天前
已完结
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
30天前
已完结
皖公网安备34019202002308
